Compare APPN & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APPN | AXGN |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2017 | 2013 |
| Metric | APPN | AXGN |
|---|---|---|
| Price | $23.47 | $43.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $29.80 | ★ $42.33 |
| AVG Volume (30 Days) | 927.0K | ★ 1.1M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.59 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $226,743,000.00 | $225,208,000.00 |
| Revenue This Year | $13.79 | $20.57 |
| Revenue Next Year | $10.56 | $16.68 |
| P/E Ratio | $1,156.50 | ★ N/A |
| Revenue Growth | ★ 28.29 | 20.21 |
| 52 Week Low | $19.79 | $9.22 |
| 52 Week High | $46.06 | $45.83 |
| Indicator | APPN | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.32 | 69.38 |
| Support Level | $22.39 | $29.48 |
| Resistance Level | $25.22 | $45.83 |
| Average True Range (ATR) | 1.24 | 1.93 |
| MACD | 0.35 | 0.35 |
| Stochastic Oscillator | 79.10 | 74.95 |
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its Domestic operations, and also has its presence Internationally.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.